Is increasing the dose of Entecavir effective in partial virological responders?
Ayse Erturk,1 Remzi Adnan Akdogan,2 Emine Parlak,3 Erkan Cure,2 Medine Cumhur Cure,4 Cinar Ozturk1 1Department of Infectious Diseases, 2Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey; 3Department of Infectious Diseases, School of Medicine, Ataturk U...
Saved in:
Main Authors: | Erturk A (Author), Adnan Akdogan R (Author), Parlak E (Author), Cure E (Author), Cumhur Cure M (Author), Ozturk C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
by: Suzuki F, et al.
Published: (2014) -
Evaluation of aortic stiffness in Gilbert syndrome patients: a protective effect of elevated bilirubin levels
by: Süleyman Yüce, et al.
Published: (2015) -
Evaluation of the relationship between c-Kit expression and mean platelet volume in classic Kaposi's sarcoma
by: Ibrahim Sehitoglu, et al.
Published: (2016) -
The effects of the insulin resistance index on the virologic response to entecavir in patients with HBeAg-positive chronic hepatitis B and nonalcoholic fatty liver disease
by: Zhu LY, et al.
Published: (2016) -
Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial
by: Cho EJ, et al.
Published: (2018)